The U.S. Food and Drug Administration on Wednesday approved Medtronic Plc’s “artificial pancreas” designed to automatically deliver the right dose of insulin to patients with type 1 diabetes.
Read more in scientificamerican.com
The U.S. Food and Drug Administration on Wednesday approved Medtronic Plc’s “artificial pancreas” designed to automatically deliver the right dose of insulin to patients with type 1 diabetes.
Read more in scientificamerican.com
